covid 19 News and Research

RSS

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

The work investigated why the children experienced milder COVID-19 illness even after a strong immune response.

1 Apr 2022

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

A new study analyzed the SARS-CoV-2 neutralizing capacity of sera samples from two-dose BNT162b2 vaccinated Japanese subjects.

1 Apr 2022

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Researchers examined the role of sialic acid-binding immunoglobulin-type lectins-1, a myeloid cell-specific receptor, in facilitating SARS-CoV-2 infection of ACE2-deficient macrophages and its effect on pro-inflammatory cytokine expression.

1 Apr 2022

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

Researchers assessed the efficacy of TMPRSS2 against SARS-CoV-2 variants of concern Alpha, Beta, Gamma, and Delta, in mice and human lung cells.

1 Apr 2022

Study investigates rapid nanopore whole-genome sequencing approach for identifying genetic variants

In a new study, researchers developed a whole-genome sequencing pipeline based on nanopore technology for the rapid identification of genetic variants.

1 Apr 2022

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania get infected yet recover within a few days. She did not get vaccinated because she worried about how a new vaccine, developed in record time, might affect her heart condition.

1 Apr 2022

COVID-19 incinerators set new record for merseyside manufacturer

A global waste management specialist has completed its first ever air-freighted incinerator system in record time, to help United Arab Emirates hospitals manage Coronavirus-infected waste.

From Inciner8 Limited 1 Apr 2022

Managing hazardous waste during the Covid-19 pandemic

In a hospital or medical environment, preventing and delaying the spread of Coronavirus goes far beyond washing hands. Good biosecurity is essential, and the safe disposal of infected waste will save lives.

From Inciner8 Limited 1 Apr 2022

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

The longest duration of SARS-CoV-2 positivity after initial diagnosis

An immunocompetent individual with prolonged SARS-CoV-2 shedding 221 days after their initial COVID-19 diagnosis.

31 Mar 2022

The mucosal antibody response to SARS-CoV-2

Researchers determine mucosal SARS-CoV-2-specific antibody levels and their neutralizing effect in pediatric and adult patients.

31 Mar 2022

How effective are household cleaning agents against SARS-CoV-2?

Researchers analyze commonly available household cleaning products to determine the most effective virucidal agent against SARS-CoV-2.

31 Mar 2022

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Early treatment of newly diagnosed COVID-19 patients with plasma extracted from individuals who have recovered from the disease reduces the need for hospitalization by more than 50%, according to a new nationwide clinical trial.

31 Mar 2022

UIC researchers projected to receive $22 million to study long COVID-19

A team of University of Illinois Chicago researchers is projected to receive approximately $22 million from the National Institutes of Health over four years to research long COVID-19.

31 Mar 2022

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Data continue to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes of COVID-19.

31 Mar 2022

Waiver will continue to be applied for COVID-19 antiviral medicines and therapeutic treatments

We are pleased to announce that the arrangements that were made for the purposes of regulation 13 of the National Health Service (Charges for Drugs and Appliances) Regulations 2015, for antiviral medicines to be supplied for free to patients who have tested positive for COVID-19 and who are eligible to receive antiviral treatments for COVID-19 via Covid Medicines Delivery Units (CMDUs), will be extended until 31st March 2023.

31 Mar 2022

covid 19 News and Research

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

Study investigates rapid nanopore whole-genome sequencing approach for identifying genetic variants

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

COVID-19 incinerators set new record for merseyside manufacturer

Managing hazardous waste during the Covid-19 pandemic

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

The longest duration of SARS-CoV-2 positivity after initial diagnosis

The mucosal antibody response to SARS-CoV-2

How effective are household cleaning agents against SARS-CoV-2?

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

UIC researchers projected to receive $22 million to study long COVID-19

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Waiver will continue to be applied for COVID-19 antiviral medicines and therapeutic treatments

KHN’s ‘What the Health?’: Funding for the next pandemic

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News